GlassScriptPhysician profile
Andrew Mcclendon Hall
NPI 1083305429
$2,128.08
in general payments reported to CMS, 2019-2025
12 companies · $1,516 in 2025
The $1,516 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $174 · 2024: $439 · 2025: $1,516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,128.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $748.81 | 2024-2025 | Cvac Aspiration System |
| Teleflex LLC | $392.09 | 2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $219.59 | 2023-2025 | Ams 700, Lithovue |
| Photocure INC | $134.40 | 2024 | Cysview |
| Integra Lifesciences Corporation | $133.30 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Janssen Biotech, INC. | $124.74 | 2025 | Carvykti, Rybrevant |
| Dendreon Pharmaceuticals LLC | $122.76 | 2025 | Provenge |
| Procept Biorobotics Corporation | $118.60 | 2024 | Aquabeam System |
| Ethicon US, LLC | $53.02 | 2024 | Dermabond Prineo, Surgiflo Hemostatic Matrix, Vistaseal |
| Urogen Pharma, INC. | $30.35 | 2024 | |
| Astellas Pharma US INC | $27.11 | 2025 | Xtandi |
| Lilly USA, LLC | $23.31 | 2025 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.